Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Sales | 25 | 0 | 0 | 0 | 25 |
| Gross Profit | 25 | N/A | N/A | N/A | 25 |
| Operating Expenses | 2,359 | 2,585 | 3,374 | 3,694 | 2,547 |
| Operating Income | -2,334 | -2,585 | -3,374 | -3,694 | -2,522 |
| Interest Expense | 13 | 13 | 11 | 7 | 1 |
| Other Income | 73 | 88 | 115 | 157 | 109 |
| Pre-tax Income | -2,274 | -2,510 | -3,270 | -3,544 | -2,414 |
| Net Income Continuous | -2,274 | -2,409 | -3,270 | -3,544 | -2,414 |
| Net Income | $-2,274 | $-2,409 | $-3,270 | $-3,544 | $-2,414 |
| EPS Basic Total Ops | -6,727.29 | -7,123.02 | -9,497.35 | -10,288.80 | -7,123.02 |
| EPS Basic Continuous Ops | -6,570.87 | -7,002.21 | -9,470.63 | -10,273.58 | -7,201.06 |
| EPS Diluted Total Ops | -6,727.29 | -7,123.02 | -9,497.35 | -10,288.80 | -7,123.02 |
| EPS Diluted Continuous Ops | -6,570.87 | -7,002.21 | -9,470.63 | -10,273.58 | -7,201.06 |
| EBITDA(a) | $-2,234 | $-2,473 | $-3,212 | $-3,553 | $-2,356 |